IGF2BP3 and neoplasm: Intriguingly, IGF2BP3 was regarded as an RNA-binding proteins (RBPs), for which several clinical trials have emerged recently to evaluate the anti-tumor efficacy of specific antisense oligonucleotide (ASO) [52, 53].